Blueshift Labs Inc

Planet Labs PBC, based in San Francisco, CA, is a leading provider of daily satellite imagery and Earth insights, empowering organizations to respond effectively to global changes. Their innovative Planet Insights Platform combines high-frequency data analytics and powerful tools, enabling clients to monitor, analyze, and act on environmental and operational challenges with confidence. With a focus on diverse industries such as agriculture, energy, and civil government, Planet Labs offers multidimensional insights that help clients expand their understanding of geographical and temporal changes. By integrating capabilities for broad area management, detailed inspections, and historical analysis, Planet Labs transforms the way organizations make informed decisions in an ever-evolving landscape. Generated from the website

Other Lab Inc, based in San Francisco, CA, is an independent research and design lab focused on innovative solutions in renewable energy and robotics. Over the past decade, the organization has raised more than $70 million in research and design contracts and successfully spun out 12 companies, all while striving for a sustainable and equitable future through collaboration and inclusivity. With a team of dedicated inventors, engineers, and scientists, Other Lab develops transformative technologies that address critical issues in energy infrastructure and healthcare. Their current projects include the design of electric scooters for reduced carbon emissions and innovative waste management solutions aimed at enhancing safety in healthcare settings. Generated from the website

Caribou Biosciences, Inc., based in Berkeley, CA, is a clinical-stage biopharmaceutical company dedicated to developing innovative genome-edited allogeneic cell therapies aimed at treating severe human diseases. Utilizing next-generation CRISPR genome-editing technology, the company focuses on creating off-the-shelf CAR-T cell therapies to enable rapid and broad patient access in the fight against hematologic malignancies. Caribou is recognized as a leader in the CRISPR field, employing its proprietary chRDNA technology to enhance the efficacy of its cell therapies through strategies such as checkpoint disruption and immune cloaking. With a commitment to advancing transformative medical treatments, the company aims to significantly improve patient outcomes in challenging health conditions. Generated from the website